Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1992 Oct;90(1):49–55. doi: 10.1111/j.1365-2249.1992.tb05830.x

Alterations in mononuclear cell tumour necrosis factor-alpha (TNF-alpha) response in patients on long term cuprophane haemodialysis.

A Y Annenkov 1, A G Strokov 1, F S Baranova 1
PMCID: PMC1554538  PMID: 1395100

Abstract

We have investigated TNF-alpha secretory response of peripheral blood mononuclear cells (PBMC) from 13 uraemic patients undergoing regular haemodialysis with cuprophane membrane (CM). Sixteen healthy subjects and five uraemic patients under conservative therapy were also studied as controls. Cells of haemodialysis patients exhibited increased TNF-alpha release in vitro in the absence of activating stimuli other than culture conditions, as compared with normal and uraemic controls. In contrast to normal cells, this spontaneous secretion of TNF-alpha from dialysis PBMC could not be significantly reduced by addition of polymyxin B to culture medium, thus indicating its independence of trace amount of lipopolysaccharide (LPS) present in the medium as contaminant. Furthermore, predialysis PBMC were considerably more sensitive to stimulation with 10(7) pg/ml of LPS under in vitro culture conditions than normal and uraemic controls. To elucidate a role of direct contact with CM in stimulation of TNF-alpha release from monocytes, PBMC were cultured on CM in vitro. Contact with CM stimulated TNF-alpha secretion from PBMC above the level of cells cultured on tissue culture plastic. This response persisted with time in culture in contrast to a transient LPS-induced TNF-alpha release. Furthermore, PBMC stimulated by contact with CM for 2 days did not lose the capacity to secrete TNF-alpha in response to a subsequent LPS stimulation, while a 2-day treatment of cells with LPS was followed by LPS refractory state. Therefore, direct contact with CM induces in PBMC a long-lasting TNF-alpha response which is not down-regulated by the acquisition of refractoriness in a manner similar to that which occurs in the case of LPS stimulation. These in vitro findings provide a possible explanation of the observation that predialysis PBMC exhibit elevated TNF-alpha secretory capacity.

Full text

PDF
49

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson U., Adolf G., Dohlsten M., Möller G., Sjögren H. O. Characterization of individual tumor necrosis factor alpha-and beta-producing cells after polyclonal T cell activation. J Immunol Methods. 1989 Oct 24;123(2):233–240. doi: 10.1016/0022-1759(89)90227-5. [DOI] [PubMed] [Google Scholar]
  2. Betz M., Haensch G. M., Rauterberg E. W., Bommer J., Ritz E. Cuprammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complement. Kidney Int. 1988 Jul;34(1):67–73. doi: 10.1038/ki.1988.146. [DOI] [PubMed] [Google Scholar]
  3. Bingel M., Arndt W., Schulze M., Floege J., Shaldon S., Koch K. M., Götze O. Comparative study of C5a plasma levels with different hemodialysis membranes using an enzyme-linked immunosorbent assay. Nephron. 1989;51(3):320–324. doi: 10.1159/000185316. [DOI] [PubMed] [Google Scholar]
  4. Bingel M., Lonnemann G., Koch K. M., Dinarello C. A., Shaldon S. Plasma interleukin-1 activity during hemodialysis: the influence of dialysis membranes. Nephron. 1988;50(4):273–276. doi: 10.1159/000185186. [DOI] [PubMed] [Google Scholar]
  5. Blumenstein M., Schmidt B., Ward R. A., Ziegler-Heitbrock H. W., Gurland H. J. Altered interleukin-1 production in patients undergoing hemodialysis. Nephron. 1988;50(4):277–281. doi: 10.1159/000185187. [DOI] [PubMed] [Google Scholar]
  6. Butler L. D., Layman N. K., Cain R. L., Riedl P. E., Mohler K. M., Bobbitt J. L., Belagajie R., Sharp J., Bendele A. M. Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacologic intervention. Clin Immunol Immunopathol. 1989 Dec;53(3):400–421. doi: 10.1016/0090-1229(89)90003-2. [DOI] [PubMed] [Google Scholar]
  7. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  8. Cavaillon J. M., Fitting C., Haeffner-Cavaillon N. Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages. Eur J Immunol. 1990 Feb;20(2):253–257. doi: 10.1002/eji.1830200204. [DOI] [PubMed] [Google Scholar]
  9. Chollet-Martin S., Stamatakis G., Bailly S., Mery J. P., Gougerot-Pocidalo M. A. Induction of tumour necrosis factor-alpha during haemodialysis. Influence of the membrane type. Clin Exp Immunol. 1991 Feb;83(2):329–332. doi: 10.1111/j.1365-2249.1991.tb05637.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Debets J. M., van der Linden C. J., Spronken I. E., Buurman W. A. T cell-mediated production of tumour necrosis factor-alpha by monocytes. Scand J Immunol. 1988 May;27(5):601–608. doi: 10.1111/j.1365-3083.1988.tb02388.x. [DOI] [PubMed] [Google Scholar]
  11. Docci D., Bilancioni R., Baldrati L., Capponcini C., Turci F., Feletti C. Elevated acute phase reactants in hemodialysis patients. Clin Nephrol. 1990 Aug;34(2):88–91. [PubMed] [Google Scholar]
  12. Eierman D. F., Johnson C. E., Haskill J. S. Human monocyte inflammatory mediator gene expression is selectively regulated by adherence substrates. J Immunol. 1989 Mar 15;142(6):1970–1976. [PubMed] [Google Scholar]
  13. Fong Y., Lowry S. F. Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunopathol. 1990 May;55(2):157–170. doi: 10.1016/0090-1229(90)90094-7. [DOI] [PubMed] [Google Scholar]
  14. Henderson L. W. Symptomatic hypotension during hemodialysis. Kidney Int. 1980 May;17(5):571–576. doi: 10.1038/ki.1980.67. [DOI] [PubMed] [Google Scholar]
  15. Henter J. I., Söder O., Andersson U. Identification of individual tumor necrosis factor/cachectin-producing cells after lipopolysaccharide induction. Eur J Immunol. 1988 Jul;18(7):983–988. doi: 10.1002/eji.1830180703. [DOI] [PubMed] [Google Scholar]
  16. Honkanen E., Grönhagen-Riska C., Teppo A. M., Maury C. P., Meri S. Acute-phase proteins during hemodialysis: correlations with serum interleukin-1 beta levels and different dialysis membranes. Nephron. 1991;57(3):283–287. doi: 10.1159/000186276. [DOI] [PubMed] [Google Scholar]
  17. Knudsen P. J., Leon J., Ng A. K., Shaldon S., Floege J., Koch K. M. Hemodialysis-related induction of beta-2-microglobulin and interleukin-1 synthesis and release by mononuclear phagocytes. Nephron. 1989;53(3):188–193. doi: 10.1159/000185743. [DOI] [PubMed] [Google Scholar]
  18. Krause T. J., Robertson F. M., Liesch J. B., Wasserman A. J., Greco R. S. Differential production of interleukin 1 on the surface of biomaterials. Arch Surg. 1990 Sep;125(9):1158–1160. doi: 10.1001/archsurg.1990.01410210084013. [DOI] [PubMed] [Google Scholar]
  19. Lonnemann G., Bingel M., Floege J., Koch K. M., Shaldon S., Dinarello C. A. Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis. Kidney Int. 1988 Jan;33(1):29–35. doi: 10.1038/ki.1988.5. [DOI] [PubMed] [Google Scholar]
  20. Miller K. M., Rose-Caprara V., Anderson J. M. Generation of IL-1-like activity in response to biomedical polymer implants: a comparison of in vitro and in vivo models. J Biomed Mater Res. 1989 Sep;23(9):1007–1026. doi: 10.1002/jbm.820230904. [DOI] [PubMed] [Google Scholar]
  21. Modai D., Berman S., Weissgarten J., Klinovsky E., Cohn M., Averbukh Z. Induction of suppressor cell activity in normal peripheral blood mononuclear cells by sera from predialytic uremic patients. Int Arch Allergy Appl Immunol. 1990;92(3):268–271. doi: 10.1159/000235188. [DOI] [PubMed] [Google Scholar]
  22. Owen-Schaub L. B., de Mars M., Murphy E. C., Jr, Grimm E. A. IL-2 dose regulates TNF-alpha mRNA transcription and protein secretion in human peripheral blood lymphocytes. Cell Immunol. 1991 Jan;132(1):193–200. doi: 10.1016/0008-8749(91)90018-7. [DOI] [PubMed] [Google Scholar]
  23. Paydaş S., Aksu H. S., Paydaş S., Karademir M., Gürçay A. A. Plasma levels of tumor necrosis factor alpha during hemodialysis. Nephron. 1991;57(4):477–478. doi: 10.1159/000186352. [DOI] [PubMed] [Google Scholar]
  24. Robinson P. J., Rosen S. M. Pyrexial reactions during haemodialysis. Br Med J. 1971 Mar 6;1(5748):528–530. doi: 10.1136/bmj.1.5748.528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rosen H., Gordon S. Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. J Exp Med. 1987 Dec 1;166(6):1685–1701. doi: 10.1084/jem.166.6.1685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Schiller B., Ziegler-Heitbrock H. W., Meyer N., Schmidt B., Blumenstein M. Monocyte phenotype and interleukin-1 production in patients undergoing haemodialysis. Nephron. 1991;59(4):573–579. doi: 10.1159/000186646. [DOI] [PubMed] [Google Scholar]
  27. Schindler R., Lonnemann G., Shaldon S., Koch K. M., Dinarello C. A. Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int. 1990 Jan;37(1):85–93. doi: 10.1038/ki.1990.12. [DOI] [PubMed] [Google Scholar]
  28. Shaldon S., Dinarello C., Port F., Kluger M. Interleukin-1: the pros and cons of its clinical relevance. Artif Organs. 1988 Jun;12(3):221–221. doi: 10.1111/j.1525-1594.1988.tb02759.x. [DOI] [PubMed] [Google Scholar]
  29. Stokes D. C., Shenep J. L., Fishman M., Hildner W. K., Bysani G. K., Rufus K. Polymyxin B prevents lipopolysaccharide-induced release of tumor necrosis factor-alpha from alveolar macrophages. J Infect Dis. 1989 Jul;160(1):52–57. doi: 10.1093/infdis/160.1.52. [DOI] [PubMed] [Google Scholar]
  30. Treves A. J., Barak V., Tal T., Fuks Z. Constitutive secretion of interleukin 1 by human monocytes. Eur J Immunol. 1983 Aug;13(8):647–651. doi: 10.1002/eji.1830130808. [DOI] [PubMed] [Google Scholar]
  31. Yamagami S., Yoshihara H., Kishimoto T., Sugimura T., Niwa M., Maekawa M. Cuprophan membrane induces interleukin-1 activity. ASAIO Trans. 1986 Jul-Sep;32(1):98–101. [PubMed] [Google Scholar]
  32. Zuckerman S. H., Evans G. F., Snyder Y. M., Roeder W. D. Endotoxin-macrophage interaction: post-translational regulation of tumor necrosis factor expression. J Immunol. 1989 Aug 15;143(4):1223–1227. [PubMed] [Google Scholar]
  33. van Deventer S. J., Büller H. R., ten Cate J. W., Aarden L. A., Hack C. E., Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood. 1990 Dec 15;76(12):2520–2526. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES